Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis.

[1]  P. Davis.  Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. , 2015, The American review of respiratory disease.

[2]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[3]  F. Fowkes.  Epidemiology of Chronic Venous Insufficiency , 1996 .

[4]  M. Corey,et al.  CFTR gene variant for patients with congenital absence of vas deferens. , 1995, American journal of human genetics.

[5]  B. Kerem,et al.  CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. , 1995, American journal of human genetics.

[6]  Arie,et al.  Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. , 1995, The New England journal of medicine.

[7]  M. Knowles,et al.  In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. , 1995, Human gene therapy.

[8]  P. Pignatti,et al.  Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. , 1995, Human molecular genetics.

[9]  E. Ernst,et al.  Ultrasound for Cutaneous Wound Healing , 1995 .

[10]  J C Olsen,et al.  A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. , 1994, The New England journal of medicine.

[11]  R. Boucher,et al.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. , 1994, Science.

[12]  L. Tsui,et al.  A mutation in CFTR produces different phenotypes depending on chromosomal background , 1993, Nature Genetics.

[13]  J. Lafitte,et al.  Sweat chloride and ΔF508 mutation in chronic bronchitis or bronchiectasis , 1993, The Lancet.

[14]  D. Geddes,et al.  Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens. , 1993, Human molecular genetics.

[15]  B. Wilfond,et al.  Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols. , 1993, American journal of human genetics.

[16]  Ronald G. Crystal,et al.  Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA , 1993, Nature Genetics.

[17]  L. Tsui,et al.  The spectrum of cystic fibrosis mutations. , 1992, Trends in genetics : TIG.

[18]  R. Crystal,et al.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. , 1992, The Journal of clinical investigation.

[19]  M. Corey,et al.  Genetic determination of exocrine pancreatic function in cystic fibrosis. , 1992, American journal of human genetics.

[20]  M. White,et al.  Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. , 1992 .

[21]  C. McCollum,et al.  A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. , 1992, The European journal of surgery = Acta chirurgica.

[22]  C. McCollum,et al.  Prevalence of venous disease: a community study in west London. , 1992, The European journal of surgery = Acta chirurgica.

[23]  L. Tsui,et al.  Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels. , 1991, The New England journal of medicine.

[24]  F. Accurso,et al.  Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. , 1991, The New England journal of medicine.

[25]  R. Slavin,et al.  Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. , 1991, The Journal of allergy and clinical immunology.

[26]  J. Sninsky,et al.  Recent advances in the polymerase chain reaction , 1991, Science.

[27]  L. Tsui,et al.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. , 1991, Genomics.

[28]  F. Collins,et al.  Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Tsui,et al.  A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein , 1990, Nature.

[30]  H. Kazazian.  The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. , 1990, Seminars in hematology.

[31]  H. S. Randhawa,et al.  Concomitant allergic Aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence of allergic bronchopulmonary aspergillosis. , 1990, Annals of allergy.

[32]  P. Jones,et al.  Oxpentifylline treatment of venous ulcers of the leg. , 1990, BMJ.

[33]  M. Knowles,et al.  Mild cystic fibrosis in a consanguineous family. , 1989, Annals of internal medicine.

[34]  A L Dannenberg,et al.  The epidemiology of varicose veins: the Framingham Study. , 1988, American journal of preventive medicine.

[35]  S. Murphy.  Cystic fibrosis in adults: diagnosis and management. , 1987, Clinics in Chest Medicine.

[36]  R. Patterson,et al.  Allergic bronchopulmonary aspergillosis. Model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. , 1987, Chest.

[37]  P. Davis,et al.  Pulmonary abnormalities in obligate heterozygotes for cystic fibrosis. , 1987, Thorax.

[38]  V. Kurup,et al.  A familial occurrence of allergic bronchopulmonary aspergillosis: a probable environmental source. , 1985, The Journal of allergy and clinical immunology.

[39]  J J Dale,et al.  Chronic ulceration of the leg: extent of the problem and provision of care. , 1985, British medical journal.

[40]  R. Patterson,et al.  Application of enzyme-linked immunosorbent assay (ELISA) in diagnosis of allergic bronchopulmonary aspergillosis. , 1982, The Journal of laboratory and clinical medicine.

[41]  P. di Sant'Agnese,et al.  Low sweat electrolytes in a patient with cystic fibrosis. , 1980, The American journal of medicine.

[42]  L. P. Ormerod,et al.  Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood. , 1980, Archives of disease in childhood.

[43]  R. Schwartz,et al.  Aspergillosis and atopy in cystic fibrosis. , 1979, The American review of respiratory disease.

[44]  V. Kurup,et al.  A familial occurrence of allergic bronchopulmonary aspergillosis. , 1979, Annals of internal medicine.

[45]  B. Cooper,et al.  Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. , 1977, Annals of internal medicine.

[46]  L. Kothari,et al.  Congenital bilateral absence of the vas deferens. , 1976, International surgery.

[47]  J. Batten,et al.  Precipitating antibodies to aspergillus fumigatus in cystic fibrosis. , 1967, Lancet.

[48]  Milan Macek,et al.  Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene , 1997, Human mutation.

[49]  E. Girodon,et al.  Frequent Occurrence of the CFTR Intron 8 (TG)n 5T Allele in Men with Congenital Bilateral Absence of the Vas Deferens , 1995, European journal of human genetics : EJHG.

[50]  J. Cheadle,et al.  Population variation of common cystic fibrosis mutations , 1994 .

[51]  J. Lafitte,et al.  Sweat chloride and delta F508 mutation in chronic bronchitis or bronchiectasis. , 1993, Lancet.

[52]  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 45-1993. A 23-year-old asthmatic man with pulmonary infiltrates and hilar lymphadenopathy. , 1993, The New England journal of medicine.

[53]  C. Barbarino,et al.  Pentoxifylline in the treatment of venous leg ulcers. , 1992, Current medical research and opinion.

[54]  G. Cutting,et al.  Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. , 1992, American journal of human genetics.

[55]  B. Kerem.  Identification of the cystic fibrosis gene: genetic analysis , 1989 .

[56]  P. Greenberger,et al.  Allergic bronchopulmonary aspergillosis and fungoses. , 1988, Clinics in chest medicine.

[57]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[58]  J. Kalbfleisch,et al.  Allergic bronchopulmonary aspergillosis in cystic fibrosis. , 1984, The Journal of allergy and clinical immunology.

[59]  Batten Jc.  Allergic aspergillosis in cystic fibrosis. , 1967 .

[60]  J. Batten.  Allergic aspergillosis in cystic fibrosis. , 1967, Bibliotheca paediatrica.